Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 95.3%

Neg 95.3% Neu 0% Pos 0%

Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.